Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples